Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Immunogenicity and safety of pandemic H1N1 2009 influenza vaccine for HIV-1 patients.

Jilich D, Havlíčková M, Veselý D, Rozsypal H, Jiřincová H, Staňková M, Kynčl J, Malý M, Machala L.

Acta Virol. 2012;56(4):349-51. No abstract available.

PMID:
23237093
2.

Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity.

Cooper CL.

Curr Opin Infect Dis. 2012 Feb;25(1):26-35. doi: 10.1097/QCO.0b013e32834ef56c. Review.

PMID:
22183114
3.

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.

Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, Frimmel S, Riebold D, Reisinger EC.

Vaccine. 2011 Feb 1;29(6):1228-34. doi: 10.1016/j.vaccine.2010.11.092. Epub 2010 Dec 15.

PMID:
21167116
4.

Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.

Van der Vliet D, Pepin S, Lambert M, Fauchoux N, Donazzolo Y, Dupuy M, Dakowski C, Denis M.

Hum Vaccin. 2010 Oct;6(10):823-8. Epub 2010 Oct 1.

PMID:
20935517
5.

Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain.

Skowronski DM, Janjua NZ, Hottes TS, De Serres G.

Clin Infect Dis. 2011 Mar 15;52(6):831-2; author reply 832-3. doi: 10.1093/cid/cir036. No abstract available.

PMID:
21367740
6.

Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.

Tandale BV, Pawar SD, Mishra AC.

Vaccine. 2012 Mar 9;30(12):2043-4. doi: 10.1016/j.vaccine.2011.10.008. Epub 2011 Oct 14. No abstract available.

PMID:
22001279
7.

Seasonal influenza vaccination and the 2009 pandemic.

Mercer G, Kelly H.

Clin Infect Dis. 2011 Mar 15;52(6):828-9; author reply 830-1. doi: 10.1093/cid/cir035. No abstract available.

PMID:
21367738
8.

Acute systemic inflammation induced by influenza A (H1N1) vaccination causes a deterioration in endothelial function in HIV-infected patients.

Vlachopoulos C, Xaplanteris P, Sambatakou H, Mariolis E, Bratsas A, Christoforatou E, Miliou A, Aznaouridis K, Stefanadis C.

HIV Med. 2011 Nov;12(10):594-601. doi: 10.1111/j.1468-1293.2011.00935.x. Epub 2011 Jun 5.

9.

Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan.

Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, Maeda A, Li P, Gillard P, Roman F.

Hum Vaccin. 2010 Nov;6(11):888-93. Epub 2010 Nov 1.

PMID:
20980795
10.

Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults.

Palma P, Romiti ML, Bernardi S, Pontrelli G, Mora N, Santilli V, Tchidjou HK, Aquilani A, Cotugno N, Alghisi F, Lucidi V, Rossi P, Douagi I.

Biologicals. 2012 Mar;40(2):134-9. doi: 10.1016/j.biologicals.2011.12.001. Epub 2012 Jan 20.

PMID:
22261282
11.

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals.

Kajaste-Rudnitski A, Galli L, Nozza S, Tambussi G, Di Pietro A, Pellicciotta G, Monti A, Mascagni P, Moro M, Vicenzi E.

AIDS. 2011 Jan 14;25(2):177-83. doi: 10.1097/QAD.0b013e328341afa8.

PMID:
21150561
12.

Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease.

Ormsby CE, de la Rosa-Zamboni D, Vázquez-Pérez J, Ablanedo-Terrazas Y, Vega-Barrientos R, Gómez-Palacio M, Murakami-Ogasawara A, Ibarra-Ávalos JA, Romero-Rodríguez D, Avila-Ríos S, Reyes-Terán G.

AIDS. 2011 Feb 20;25(4):435-9. doi: 10.1097/QAD.0b013e3283434844.

PMID:
21139486
13.

Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.

Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, Cyr L, Cote S, Baz M, Sampalis J, Trautman L, Sékaly RP, Boivin G.

Vaccine. 2011 Feb 4;29(7):1359-63. doi: 10.1016/j.vaccine.2010.12.023. Epub 2010 Dec 23.

PMID:
21185423
14.

How did the 2008-2009 seasonal influenza vaccine affect the pandemic?

Glezen WP.

Clin Infect Dis. 2010 Dec 15;51(12):1380-2. doi: 10.1086/657312. Epub 2010 Nov 10. No abstract available.

PMID:
21067354
15.

Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.

Dikow R, Eckerle I, Ksoll-Rudek D, Hampel H, Schwenger V, Zeier M, Schnitzler P, Sommerer C.

Am J Kidney Dis. 2011 May;57(5):716-23. doi: 10.1053/j.ajkd.2010.11.031. Epub 2011 Feb 23.

PMID:
21349617
16.

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P.

Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.

PMID:
21075164
17.

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus.

Zuccotti GV, Pariani E, Scaramuzza A, Santoro L, Giani E, Macedoni M, Gazzarri A, Anselmi G, Amendola A, Zanetti A.

Diabet Med. 2011 Dec;28(12):1530-6. doi: 10.1111/j.1464-5491.2011.03449.x.

PMID:
21916971
18.

Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients.

Labriola L, Hombrouck A, Maréchal C, Van Gucht S, Brochier B, Thomas I, Jadoul M, Goubau P.

Nephrol Dial Transplant. 2011 Apr;26(4):1424-8. doi: 10.1093/ndt/gfq782. Epub 2011 Jan 27.

PMID:
21273236
19.

Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.

Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR.

Vaccine. 2011 Nov 15;29(49):9209-13. doi: 10.1016/j.vaccine.2011.09.103. Epub 2011 Oct 3.

PMID:
21974995
20.

Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism.

Yin JK, Wang H, Skinner SR, Salkeld G, Booy R.

Aust N Z J Public Health. 2011 Aug;35(4):393-4. doi: 10.1111/j.1753-6405.2011.00748.x. No abstract available.

PMID:
21806738

Supplemental Content

Support Center